AGRINFO AGRINFO logo

THE LATEST ON EU AGRI-FOOD POLICIES IMPACTING LOW- AND MIDDLE-INCOME COUNTRIES

2024/1037, 2024/1046, 2024/1047, 2024/1048

Latest novel food authorisations – April 2024

  • Food safety
  • Novel/traditional foods

Summary

The EU has authorised the sale of the following novel foods on its market:

  • a monosodium salt of L-5-methyltetrahydrofolic acid
  • beta-glucan from Euglena gracilis microalgae (paramylon)
  • a 3′-sialyllactose sodium salt obtained by microbial fermentation using Escherichia coli NEO3
  • a protein concentrate from water lentil (Lemna gibba and Lemna minor)
  • calcidiol monohydrate as a form of vitamin D.

EU authorises several novel foods

Commission Implementing Regulations:

(EU) 2024/1037 authorising the placing on the market of monosodium salt of L-5-methyltetrahydrofolic acid as a novel food and amending Implementing Regulation (EU) 2017/2470

(EU) 2024/1046 authorising the placing on the market of beta-glucan from Euglena gracilis microalgae as a novel food and amending Implementing Regulation (EU) 2017/247

(EU) 2024/1047 authorising the placing on the market of 3′-Sialyllactose sodium salt produced using a derivative strain of Escherichia coli W (ATCC 9637) as a novel food and amending Implementing Regulation (EU) 2017/2470

(EU) 2024/1048 authorising the placing on the market of protein concentrate from Lemna gibba and Lemna minor as a novel food and amending Implementing Regulation (EU) 2017/2470

(EU) 2024/1052 authorising the placing on the market of calcidiol monohydrate as a novel food and amending Implementing Regulation (EU) 2017/2470

Update

The EU has authorised the sale of the following novel foods on its market:

  • a monosodium salt of L-5-methyltetrahydrofolic acid
  • beta-glucan from Euglena gracilis microalgae (paramylon)
  • a 3′-sialyllactose sodium salt obtained by microbial fermentation using Escherichia coli NEO3
  • a protein concentrate from water lentil (Lemna gibba and Lemna minor)
  • calcidiol monohydrate as a form of vitamin D.

Impacted Products

Milk products (pasteurised, sterilised, UHT), unflavoured and flavoured fermented milk products, flavoured beverages, cereal bars, infant formula, follow-on formula, processed cereal-based food and baby food, milk-based drinks and similar products, diet replacement foods (for weight control), special medical foods, food supplements (except for young children)

What is changing?

The EU has authorised placing on the market the following novel foods:

  • a monosodium salt of L-5-methyltetrahydrofolic acid (company applicant: Merck & Cie KmG)
  • beta-glucan from Euglena gracilis microalgae (Kemin Foods L.C.)
  • a 3′-sialyllactose sodium salt from Escherichia coli NEO3 (Kyowa Hakko Bio Co., Ltd)
  • protein concentrate from water lentil (ABC Kroos BV)
  • calcidiol monohydrate as a form of vitamin D (DSM Nutritional Products Ltd).

These novel foods will be included in the Union list of novel foods (Regulation (EU) 2017/2470). Calcidiol monohydrate will also be included in the list of vitamin and mineral substances (Directive 2002/46/EC, Annex II) in order to allow its use as a source of vitamin D in food supplements (G/TBT/N/EU/1082).

Only the company that applied for authorisation may sell the respective novel food on the EU market over the next 5 years, unless they allow other companies to sell it, or if another company obtains a novel food authorisation without reference to the scientific data used by the original applicant, which is data protected.

Why?

The European Food Safety Authority (EFSA), in its scientific opinions (2023a, 2023b, 2023c, 2023d), concluded that these novel foods are safe under the applicants’ proposed conditions of use.

Timeline

These novel foods may be placed on the market from 30 April 2024 (1 May 2024 for calcidiol monohydrate). The applicant companies’ data protection rights end on 30 April 2029 (1 May 2029 for calcidiol monohydrate).

Recommended Actions

Comments on the proposal to include calcidiol monohydrate in the list of vitamin and mineral substances that may be used in the manufacture of food supplements can be submitted via the National TBT notification authority of the country concerned to the EU TBT Enquiry Point until 6 October 2024.

Background

Only novel foods authorised and included in the Union list of novel foods may be placed on the market within the EU (Regulation 2015/2283).

On 16 May 2018, DSM Nutritional Products Ltd submitted an application to place calcidiol monohydrate on the EU market as a novel food and a form of vitamin D.

On 28 December 2018, ABC Kroos BV submitted an application to place protein concentrate from water lentil (Lemna gibba and Lemna minor) on the EU market.

On 15 August 2019, Kemin Foods L.C. submitted an application to place beta-glucan from Euglena gracilis microalgae (paramylon) on the EU market.

On 12 November 2020, Merck & Cie KmG submitted its application for authorisation to place the monosodium salt of L-5-methyltetrahydrofolic acid on the EU market as a novel food and a source of bioavailable folate.

Resources

Sources

Regulation (EU) 2024/1037 authorising the placing on the market of monosodium salt of L-5-methyltetrahydrofolic acid as a novel food

Regulation (EU) 2024/1046 authorising the placing on the market of beta-glucan from Euglena gracilis microalgae as a novel food

Regulation (EU) 2024/1047 authorising the placing on the market of 3′-Sialyllactose sodium salt produced using a derivative strain of Escherichia coli W (ATCC 9637) as a novel food

Regulation (EU) 2024/1048 authorising the placing on the market of protein concentrate from Lemna gibba and Lemna minor as a novel food

Regulation (EU) 2024/1052 authorising the placing on the market of calcidiol monohydrate as a novel food

Draft Commission Regulation as regards calcidiol monohydrate used in the manufacture of food supplements

Disclaimer: Under no circumstances shall COLEAD be liable for any loss, damage, liability or expense incurred or suffered that is claimed to have resulted from the use of information available on this website or any link to external sites. The use of the website is at the user’s sole risk and responsibility. This information platform was created and maintained with the financial support of the European Union. Its contents do not, however, reflect the views of the European Union.

EU authorises several novel foods

Regulation

Regulations:

  • 2024/1037 authorising the placing on the market of monosodium salt of L-5-methyltetrahydrofolic acid as a novel food
  • 2024/1046 authorising the placing on the market of beta-glucan from Euglena gracilis microalgae as a novel food
  • 2024/1047 authorising the placing on the market of 3′-Sialyllactose sodium salt produced using a derivative strain of Escherichia coli W (ATCC 9637) as a novel food
  • 2024/1048 authorising the placing on the market of protein concentrate from Lemna gibba and Lemna minor as a novel food
  • 2024/1052 authorising the placing on the market of calcidiol monohydrate as a novel food

Draft Commission Regulation as regards calcidiol monohydrate used in the manufacture of food supplements

What is changing and why?

The EU has authorised the following novel foods to be placed on the market:

  • a monosodium salt of L-5-methyltetrahydrofolic acid
  • beta-glucan from Euglena gracilis microalgae (paramylon)
  • a 3′-sialyllactose sodium salt obtained by microbial fermentation using Escherichia coli NEO3
  • a protein concentrate from water lentil (Lemna gibba and Lemna minor)
  • calcidiol monohydrate as a source of vitamin D in food supplements.

These novel foods will be included in the Union list of novel foods (Regulation (EU) 2017/2470). Only the company that applied for each authorisation can sell the novel food on the EU market over the next 5 years, unless they give permission other companies to sell them, or if another company obtains a novel food authorisation without using the scientific data used by the original applicant, which is data protected.

Actions

Comments on the proposal to include calcidiol monohydrate in the list of vitamin and mineral substances that may be used in the manufacture of food supplements can be submitted via the National TBT notification authority of the country concerned to the EU TBT Enquiry Point until 6 October 2024.

Timeline

ABC Kroos BV, Merck & Cie KmG, Kemin Foods L.C., and Kyowa Hakko Bio Co., Ltd have exclusive rights to put their novel foods on the market from 30 April 2024 until the end date of the data protection, 30 April 2029.

DSM Nutritional Products Ltd has exclusive rights to put its novel food on the market from 1 May 2024 until the end date of the data protection, 1 May 2029.

Disclaimer: Under no circumstances shall COLEAD be liable for any loss, damage, liability or expense incurred or suffered that is claimed to have resulted from the use of information available on this website or any link to external sites. The use of the website is at the user’s sole risk and responsibility. This information platform was created and maintained with the financial support of the European Union. Its contents do not, however, reflect the views of the European Union.